SECOND AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • November 3rd, 2011 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledNovember 3rd, 2011 Company Industry JurisdictionTHIS SECOND AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENT (the "Second Amendment") is made and entered into on November 19, 2004 (the "Second Amendment Effective Date"), by and between NPS Pharmaceuticals, Inc. ("NPS") and Amgen Inc. ("Amgen"). NPS and Amgen are referred to in this Second Amendment individually as a "Party" and collectively as the "Parties."
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • October 21st, 2011 • California
Contract Type FiledOctober 21st, 2011 JurisdictionWHEREAS, NPS and Amgen have previously entered into a Development and License Agreement effective as of December 27, 1995 (the "Original Agreement"), as amended by that certain First Amendment to Development and License Agreement (the "First Amendment") and this Second Amendment, each effective as of the Second Amendment Effective Date (collectively, the "Agreement"); and